Predict your next investment

HEALTHCARE | Medical Equipment & Supplies

See what CB Insights has to offer

Founded Year

1997

Stage

Angel - III | Dead

Total Raised

$990K

Last Raised

$580K

About CuMedica

CuMedica is a privately held company founded by Dr Christopher Underwood. It has developed a new biomaterials technology in collaboration with the US company Greene Tweed & Co Inc.The base materials employed are the class of polymers known as perfluoroelastomers. These materials have been used in state-of-the-art sealing applications in the aerospace and semiconductor industries for some years, principally because of their immunity to degradation in highly aggressive environments. These materials are inert and non-toxic but have not previously been used for any medical implant applications.CuMedica has applied unique fabrication techniques to the base materials which independent review confirms make them ideally suited to a wide variety of medical implant applications. For example, cardiovascular implants, soft tissue implants, barrier coating for stents, endovascular applications, orthopaedic applications, artificial corneas, and scaffold matrices (for use in tissue engineering applications).The business model is to act as a technology licensing company, granting licenses to use the base materials as modified to major corporations for the sort of applications highlighted above.

CuMedica Headquarter Location

The Campus Ventures Centre University of Manchester, Oxford Road

Manchester, M13 9PL,

United Kingdom

44 161 276 8318

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.